Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasm Metastasis 1Kidney Neoplasms 1Kidney Failure, Chronic 1Carcinoma, Renal Cell 1

Interventions

cabozantinib 5Nivolumab 4Ipilimumab 4Axitinib 4pembrolizumab 3Blood Specimen Collection 3zimberelimab 2atezolizumab 2Surveys and Questionnaires 2Sunitinib 2Irinotecan 2temsirolimus 1spartalizumab 1salicylhydroxamic acid 1palbociclib 1orellanine 1olaparib 1liposomal doxorubicin 1lenvatinib 1gallium Ga 68 dotatate 1fludarabine 1brodalumab 1belzutifan 1aldesleukin 1adagrasib 1Vincristine 1Temozolomide 1Taxes 1Selenomethionine 1Ropivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × orellanine × 90 days × Clear all
NCT05287945 2026-05-22

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Oncorena AB

Phase 1/2 Recruiting
75 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡